CSL Seqirus is a leading global vaccines company focused on developing and manufacturing influenza vaccines and pandemic preparedness solutions. With research, production, and distribution capabilities across the United States, United Kingdom, and Australia, it aims to protect public health by reducing the impact of influenza through vaccination programs and related interventions.
No recent deals for this company.